Sign in

CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company

CERENOME, INC.

Sign in to watch
Ticker
CNSY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330827593
Phone
737.255.7194
Business address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
  1. EFFECT Other Notice of Effectiveness
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. 10-Q/A Report 10-Q/A
  4. S-3/A Offering Registration Statement
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Material agreement · Other events
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Open-market sale Chief Executive Officer sold 29,145 shares at an average $15.19 ($442,814)
  9. 4 Grant or award Director acquired 10,550 shares (grant or award)
  10. 4 Grant or award Director acquired 10,550 shares (grant or award)
  11. 4 Grant or award Director acquired 10,550 shares (grant or award)
  12. 4 Grant or award Director acquired 10,550 shares (grant or award)
  13. 4 Grant or award Director acquired 10,550 shares (grant or award)
  14. 4 Grant or award Director acquired 10,550 shares (grant or award)
  15. UPLOAD Other SEC-generated Letter
  16. S-3 Offering Registration Statement
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 8-K Event Material agreement · Unregistered share sale
  20. 4 Grant or award Director acquired 21,000 shares (grant or award)

Page 44 of 74 · 1,465 filings